Arcadia Biosciences Licenses Broad Institute CRISPR IP – GenomeWeb
|
Arcadia Biosciences Licenses Broad Institute CRISPR IP
GenomeWeb NEW YORK (GenomeWeb) – Ag-bio firm Arcadia Biosciences announced today that has it acquired a worldwide, nonexclusive license to the Broad Institute’s intellectual property on CRISPR-Cas9 genome-editing technology. According to Arcadia, the … Arcadia Biosciences To Accelerate Agricultural Trait Development with CRISPR-Cas9Business Wire (press release) |
|
Modulating T-cell metabolism uncovers new technology for enhancing immunotherapy
EurekAlert (press release) “Considering the central importance of TILs for cancer immunotherapy, we believe that our findings may have critical implications to boost the efficacy of T cell-based therapies.” This study by Ertl and colleagues shows that low oxygen levels combined … |
|
Outside-in reprogramming: Antibody study suggests a better way to make stem cells
Phys.Org The scientists could then observe which of the cells began forming stem cell colonies—indicating that one of the antibodies produced by those cells had successfully replaced the functions of Sox2 and c-Myc and triggered the switch in cell identity. |
|
Outside-in reprogramming: Antibody study suggests a better way to make stem cells
Phys.Org The scientists could then observe which of the cells began forming stem cell colonies—indicating that one of the antibodies produced by those cells had successfully replaced the functions of Sox2 and c-Myc and triggered the switch in cell identity. |
OncLive |
Immunotherapy for HNSCC
OncLive Ezra Cohen, MD: Of course, we’re now moving into a new era of immunotherapy, something that we’ve all been excited about, first with preliminary phase I data and now with larger data sets. Barbara, we’ve got, for the first time in a little while, new … |
|
Gene therapy for cancer halted after patient death
BioNews Two trials assessing gene therapy for blood cancer have been put on hold by the US Food and Drug Administration (FDA), following a patient fatality. The therapy, known as ‘off-the-shelf’ CAR-T immunotherapy, used genetically modified immune system T … |
|
‘The Four Top’: CRISPR Over GMOs? | Endangered Foods | Banking Seeds In Vaults
KUOW News and Information Have you heard about the gene-editing breakthrough called CRISPR? It might wipe out cancer and it also might change the face of agriculture as we know it. Next, most enlightened foodies don’t realize that they consume imperiled species every day. |